RXRA
Reaktivität: Human
WB
Wirt: Kaninchen
Polyclonal
unconjugated
Applikationshinweise
ELISA (1:16000) Western Blot (0.5-3 μg/mL) The optimal working dilution should be determined by the end user.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
0.5 mg/mL
Buffer
In Tris saline, pH 7.3 (0.5 % BSA, 0.02 % sodium azide)
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20°C. Aliquot to avoid repeated freezing and thawing.
Claudel, Leibowitz, Fiévet, Tailleux, Wagner, Repa, Torpier, Lobaccaro, Paterniti, Mangelsdorf, Heyman, Auwerx: "Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 98, Issue 5, pp. 2610-5, (2001) (PubMed).
Target
Retinoid X Receptor alpha (RXRA)
(Retinoid X Receptor, alpha (RXRA))